India may need central bank support to attract dollar investments, potentially through forex deposit schemes, to cover exchange risks and offer competitive yields. Economists suggest higher subsidies from the RBI might be necessary to make such initiatives attractive for banks, especially given current global interest rates.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026